10ml Tirzepatide and How UK Mounjaro Packaging Actually Works

What the NICE and MHRA evidence tells us about licensed tirzepatide

The evidence base for tirzepatide is substantial. The SURMOUNT-1 trial, involving 2,539 adults with obesity and no diabetes, ran for 72 weeks and found average body-weight reductions of around 20–21% at the 15mg dose, results that informed the NICE technology appraisal TA1026, published in December 2024, which recommended tirzepatide for adults with a BMI of 35 or above alongside at least one weight-related condition. That recommendation was built on data gathered using the specific pen-delivered formulation that Eli Lilly submitted for authorisation. Compounded tirzepatide, including 10 ml tirzepatide prepared in vials outside the licensed supply chain, carries none of that evidence. Dosing accuracy, sterility, excipient composition and stability have not been validated in those formats by any regulatory body.

The MHRA's role here is worth understanding clearly. The UK licence covers Mounjaro's KwikPen in six strengths: 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg and 15mg. Treatment always starts at 2.5mg (a dose chosen to let the body adjust gradually) and is stepped up by a prescriber, typically at four-week intervals. That careful titration schedule was designed around the pen's fixed-dose mechanism. A 10ml vial requires the patient or a third party to draw up and inject a measured volume, which introduces variables the licensed product deliberately eliminates.

Why 10ml tirzepatide vials appear online and what the MHRA has found

The surge in demand for GLP-1 medicines since 2023 created a parallel market of compounded and counterfeit products, many sold via social media with no clinical assessment involved. The MHRA and DHSC have seized approximately 20 million doses of illegally traded weight-loss medicines (around £45m street value) and raided an illicit UK manufacturing site producing counterfeit tirzepatide pens in Northampton in October 2025. Multi-dose vials (often presented as 10ml or similar) are a format frequently associated with this grey market, partly because they can be produced cheaply and are difficult for buyers to verify.

The risks extend beyond uncertain dosing. Fake pens and vials seized in previous enforcement operations were found to contain insulin rather than the stated compound, leading to hospitalisations. You can report any suspected counterfeit or illegally sold weight-loss medicine directly via the MHRA's Yellow Card reporting service, which also accepts reports of suspected adverse reactions from legitimate medicines.

If you are comparing costs and wondering whether a 10ml vial represents better value, the Mounjaro pricing context page covers what a private prescription realistically includes in the UK and why price alone is not a reliable guide for a prescription-only medicine.

What legitimate tirzepatide looks like and how the KwikPen works

Each Mounjaro KwikPen is a single-use, pre-filled device containing four doses. The pen is dialled to deliver one fixed dose per week, no drawing up, no calculation, no syringe. Available injection sites are the abdomen, thigh or upper arm; rotating sites between injections is standard practice. Store the pen in the fridge (2–8°C): many people find keeping it in the fridge door works well as a visual reminder to use it on the same day each week. Once removed from the fridge, the pen can be kept at room temperature for a limited period, the patient information leaflet sets out the exact window, and your prescriber can walk you through that at review.

The pen format also helps with dose traceability. The batch number, strength and expiry date are printed on the device, making it straightforward to verify what you are injecting, something that our 10ml Mounjaro information page explains further for anyone who has encountered vial-format offers and wants to understand the difference. For anyone who has been offered tirzepatide in a different format and wants to understand their options, our full tirzepatide information page sets out the UK-licensed picture in detail, and the Mounjaro overview covers the pen's practical use from first injection onwards.

How to access licensed tirzepatide through a regulated UK pharmacy

The only legal route to tirzepatide in the UK is a prescription following clinical assessment by a qualified prescriber. Through a regulated online pharmacy you can verify on the GPhC register, that process typically involves a health questionnaire, identity and weight verification, and review by a GPhC-registered independent prescriber who reads your answers personally. At nume, every consultation is reviewed the same day by a real clinician, your answers go to a prescriber's desk, not through an algorithm. If treatment is clinically appropriate, it is dispatched the same day for free next-working-day tracked delivery, in plain unbranded packaging.

Red flags that a seller is not operating within the licensed supply chain include offering tirzepatide in vial formats, supplying without any prescribing process, or prices far outside the range for authentic UK-dispensed product. Our tirzepatide 10 information page can help you understand what a legitimately dispensed product at that strength looks like, which is useful context when assessing unfamiliar sellers. If you would like to explore whether tirzepatide is clinically suitable for you through a proper assessment, you can speak to our prescribers by starting a free consultation. Our clinical team's approach is set out on the clinical team page if you want to understand who would be reviewing your case.